Evidence map›Paper›PMID 32315539›Full record

ArticleJournal of child and adolescent psychopharmacology2020

Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe.

Csaba Siffel, Matthew Page, Tricia Maxwell, Barbara Thun, Nikolaus Kolb, Mats Rosenlund, Dorothea von Bredow, Jacco Keja

Abstract read
In one paragraph

Article in Journal of child and adolescent psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Csaba SiffelGlobal Evidence and Outcomes, Data Sciences Institute, Shire, a Takeda Company, Lexington, Massachusetts, USA.
Matthew PageMarketed Products Group, Chief Medical Office, Shire, a Takeda Company, Cambridge, Massachusetts, USA.
Tricia MaxwellMarketed Products Group, Chief Medical Office, Shire, a Takeda Company, Cambridge, Massachusetts, USA.
Barbara ThunReal World Solutions, IQVIA, Munich, Germany.
Nikolaus KolbReal World Solutions, IQVIA, Munich, Germany.
Mats RosenlundReal World Solutions, IQVIA, Solna, Sweden.
Dorothea von BredowReal World Solutions, IQVIA, Munich, Germany.
Jacco KejaReal World Solutions, IQVIA, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildDrug UtilizationEuropeFemaleHumansLisdexamfetamine DimesylateMaleMiddle AgedRetrospective StudiesYoung AdultCentral Nervous System StimulantsLisdexamfetamine DimesylateADHDdrug utilizationlisdexamfetamine dimesylatetreatment patterns

Identifiers

PMID32315539
PMCPMC7475084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.